On the other hand, it has been shown that RA can induce Th17 immunity [18], which is associated with human IBDs, in the context of IL-15 and IL-6 in the intestinal mucosa and thus, it may not be beneficial as a treatment of intestinal inflammation associated with increased levels of IL-15 such as in IBD [24]. This evidence concerns the gene IL15 and inflammatory bowel disease.